| Systemic Lupus Erythematosus |
0 |
0.87 |
| Dermatitis |
0 |
0.81 |
| Lupus |
0 |
0.71 |
| Vasculitis |
0 |
0.62 |
| Pernio |
0 |
0.58 |
| Discoid Lupus Erythematosus |
0 |
0.55 |
| Digital of Foot |
0 |
0.33 |
| Finger |
0 |
0.33 |
| COVID-19 |
0 |
0.28 |
| Steroids |
0 |
0.2 |
| Otolaryngology |
0 |
0.14 |
| Nose |
0 |
0.13 |
| Skin Lesion |
0 |
0.13 |
| Arrhythmia |
0 |
0.1 |
| Calcium Channel Blockers |
0 |
0.09 |
| Antigens |
0 |
0.07 |
| Biologic Therapy |
0 |
0.07 |
| Board Certification |
0 |
0.07 |
| Calcaneal |
0 |
0.07 |
| Calcineurin Inhibitor |
0 |
0.07 |
| Calcium |
0 |
0.07 |
| Ear |
0 |
0.07 |
| Edema |
0 |
0.07 |
| Histology |
0 |
0.07 |
| Immunoglobulin A (IgA) |
0 |
0.07 |
| Osteoarthritis |
0 |
0.07 |
| Pandemic |
0 |
0.07 |
| Pathogenesis |
0 |
0.07 |
| Private Practice |
0 |
0.07 |
| Revenue and Practice Management |
0 |
0.07 |
| Sarcoidosis |
0 |
0.07 |